Trevena, Inc. Sustainability Profile
Trevena, Inc., a biopharmaceutical company headquartered in the United States, is at the forefront of developing innovative therapies for patients with serious medical conditions. Founded in 2007, Trevena has made significant strides in the industry, particularly in the areas of pain management and central nervous system disorders. The company is renowned for its unique approach to drug development, focusing on G protein-coupled receptors (GPCRs) to create safer and more effective treatments. Trevena's flagship product, Olinvyk (oliceridine), exemplifies this commitment, offering a novel option for intravenous pain relief. With a strong market position and a dedication to advancing healthcare, Trevena continues to achieve notable milestones, solidifying its reputation as a leader in the biopharmaceutical sector.
DitchCarbon Score
How does Trevena, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Trevena, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Trevena, Inc.'s reported carbon emissions
Trevena, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year. As a result, there are no specific figures regarding their Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, such as those associated with the Science Based Targets initiative (SBTi) or other industry standards. Without emissions data or reduction initiatives, it is unclear how Trevena, Inc. is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. The absence of specific commitments or targets may indicate a need for further development in their sustainability strategy.
How Carbon Intensive is Trevena, Inc.'s Industry?
How Carbon Intensive is Trevena, Inc.'s Location?
Trevena, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Trevena, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.